As PCSK9 antagonism was more efficient in patients with acute coronary syndrome when they displayed metabolic risk factors (32), we investigated the effect of the genetic deletion of PCSK9 on I/R injury in vivo in mice fed normal diets or high-fat diets. This evidence concerns the gene PCSK9 and acute coronary syndrome.